Early clinical and laboratory indicators of acute dengue illness

Journal of Infectious Diseases

Volumn 176, Issue 2, 1997, Pages 313-321

  Kalayanarooj, S ^b   Vaughn, D W ^b   Nimmannitya, S ^b   Green, S ^b   Suntayakorn, S ^b   Kunentrasai, N ^b   Viramitrachai, W ^b   Ratanachu eke, S ^b   Kiatpolpoj, S ^b   Innis, B L ^b   Rothman, A L ^b   Nisalak, A ^b   Ennis, F A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL OBSERVATION; DENGUE; DENGUE VIRUS; EARLY DIAGNOSIS; FEMALE; FEVER; HUMAN; INFANT; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THAILAND; VIRUS INFECTION;

EID: 16944364597     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514047     Document Type: Article

References (30)

1. Halstead SB. The XXth century dengue pandemic: need for surveillance and research. World Health Stat Q 1992;45:292-8.
2. Monath TP. Dengue: the risk to developed and developing countries. Proc Nail Acad Sci USA 1994;91:2395-400.
3. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988;239:476-81.
4. Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev 1990; 3:376-96.
5. Nimmannitya S. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987;18: 392-7.
6. Halstead SB. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 1989;11(suppl): S830-9.
7. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment and control. Geneva: WHO, 1986:1-58.
8. Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg 1952;1:30-50.
9. Kliks S. Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness. AIDS Res Hum Retroviruses 1990;6:993-8.
10. Rico-Hesse R. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 1990;174:479-93.
11. Gubler DJ, Trent DW. Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis 1993;2:383-93.
12. Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors for dengue shock syndrome: a prospective epidemiologic study in Rayong.Thailand. I. The 1980 outbreak. Am J Epidemiol 1984;120:653-69.
13. Halstead SB. Immunological parameters of togavirus disease syndromes. In: Schlesinger RW, ed. The togaviruses. Biology, structure, replication. New York: Academic Press, 1980:107-73.
14. Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 1994;19:500-12.
15. Malasit P. Complement and dengue haemorrhagic fever/shock syndrome. Southeast Asian J Trop Med Public Health 1987;18:316-20.
16. Bokisch VA, Top FHJ, Russell PK, Dixon FJ, Muller-Eberhard HJ. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med 1973;289:996-1000.
17. Kurane I, Rothman AL, Livingston PG, et al. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol 1994; 9:59-64.
18. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989;40: 444-51.
19. Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CDS, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 1991;88:1473-80.
20. Nisalak A, Halstead SB, Singharaj P, Udomsakdi S, Nye SW, Vinijchaikul K. Observations related to pathogenesis of dengue hemorrhagic fever. III. Virologic studies of fatal disease. Yale J Biol Med 1970;42:293-310.
21. Teeraratkul A, impakarnjanara K, Nisalak A, Nimmannitya S. Predictive value of clinical and laboratory findings for early diagnosis of dengue and dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 1990;21:696-7.
22. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997;176:322-30.
23. Nimmannitya S, Cardosa J. Dengue haemorrhagic fever. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford textbook of medicine. 3rd ed. Oxford, UK: Oxford Medical Publications, 1995.
24. Halstead SB, Nimmannitya S, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. II. Observations on disease in outpatients. Am J Trop Med Hyg 1969;18:972-83.
25. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988;38:172-80.
26. Bhamarapravati N, Tuchinda P, Boonyapaknavik V. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol 1967;61:500-10.
27. LaRussa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol 1995; 8:249-70.
28. Boonpucknavig S, Lohachitranond C, Nimmanitya S. The pattern and nature of the lymphocyte population response in dengue hemorrhagic fever. Am J Trop Med Hyg 1979;28:885-9.
29. Thisyakorn U, Nimmannitya S, Ningsanond V, Soogarun S. Atypical lymphocyte in dengue hemorrhagic fever: its value in diagnosis. Southeast Asian J Trop Med Public Health 1984;15:32-6.
30. Kuo C, Tai D, Chang-Chien C, Lan C, Chiou S, Liaw Y. Liver biochemical tests and dengue fever. Am J Trop Med Hyg 1992;47:265-70.